Piperine Extract (Standardized).

Curcumin is cleared fast by intestinal and hepatic UDP-glucuronosyltransferases before it reaches circulation. Piperine inhibits that conjugation step and also slows P-glycoprotein efflux, which together raise curcumin's plasma concentration by a large multiple.

The standardised curcuminoid complex faces the same first-pass glucuronidation as plain curcumin. Piperine is the original and most widely used answer to that clearance step, which is why the two are sold as a pair.

Resveratrol is almost entirely conjugated to glucuronide and sulfate on first pass, so very little circulates as the free molecule. Piperine slows both conjugation routes and raises the free fraction.

EGCG is methylated and glucuronidated rapidly in the gut wall and liver. Piperine reduces that conjugation and raises how much intact EGCG reaches plasma.

CoQ10 is a large lipophilic molecule with poor and variable uptake. Piperine has been reported to raise its plasma appearance, attributed to effects on intestinal transport and on the efflux pumps that return absorbed lipophiles to the lumen.

Piperine raises the plasma appearance of beta-carotene given in the same dose. The mechanism is attributed to increased intestinal permeability and reduced efflux rather than to any change in the carotenoid itself.

Piperine has been reported to raise the bioavailability of selenium from a co-administered dose. It is one of the original nutrients studied alongside the alkaloid for this effect.

Pyridoxine is among the nutrients whose plasma appearance rises when given with piperine. The effect is on intestinal handling, not on the vitamin's conversion to its active phosphate form.

Quercetin is heavily glucuronidated and sulfated in the enterocyte, the same route piperine inhibits. Co-dosing raises the circulating unconjugated fraction, and it also means the two compete for the same conjugation capacity.

Berberine's low oral uptake is driven largely by P-glycoprotein pumping it back into the gut lumen. Piperine inhibits that pump, which raises how much berberine stays absorbed.

Pterostilbene resists conjugation better than resveratrol because of its methoxy groups, but glucuronidation is still its main clearance route. Piperine slows that step further.

Piperine is added to ashwagandha capsules on the same absorption rationale used for curcumin: inhibition of intestinal glucuronidation and of P-glycoprotein efflux. The 2026 systematic review of ashwagandha on cognitive and physical function in adults covers preparations that include piperine, but it does not separate piperine-containing from piperine-free products. The pairing is therefore formulation practice with a mechanistic basis, not a measured contribution.

Ginger and black pepper are paired in culinary and traditional formulations, and both act partly through TRP channel agonism at sensory nerve endings. A 2026 systematic review of Zingiberaceae-derived interventions on memory-related outcomes in adults includes preparations formulated with piperine. Nothing in that review isolates the piperine contribution.

Boswellic acids and curcumin are routinely combined with a standardised piperine extract in the same capsule. The rationale for including piperine is its inhibition of phase II conjugation, which applies broadly to polyphenolic and terpenoid actives cleared that way. Whether boswellic acid exposure specifically rises with piperine has not been separated out in the material cited here.

Piperine slows intestinal and hepatic conjugation and reduces efflux, mechanisms that apply to fat-soluble carotenoids generally. Beta-carotene is the carotenoid where this has been examined most; lutein shares the absorption route through mixed micelles and the same conjugative clearance class. The extension to lutein is mechanistic reasoning, not a measured pair.

Lycopene is absorbed with dietary lipid into mixed micelles and cleared partly through conjugation, the step piperine slows. Any absorption gain is contingent on the meal carrying enough fat for micelle formation in the first place. This pairing rests on shared class pharmacology rather than on a lycopene-specific study.

Astaxanthin is a xanthophyll carried in lipid vehicles and subject to the same first-pass conjugation piperine inhibits. The mechanistic case is the same one that applies to beta-carotene. No study cited here measured astaxanthin exposure with and without piperine.

Silymarin flavonolignans and piperine both inhibit UDP-glucuronosyltransferases, so combining them stacks inhibition on the same clearance step rather than adding two independent effects. For a co-administered active cleared by glucuronidation, that means exposure can rise more than either ingredient alone would explain. The direction is predictable from enzymology; the magnitude in a person taking both has not been quantified here.

St Johns wort induces CYP3A4 and P-glycoprotein through the pregnane X receptor, while piperine inhibits both. Taken together the two push the same clearance machinery in opposite directions, and induction develops over days while inhibition is immediate, so the net effect changes with time on the combination. This is one of the clearer reasons to keep the two apart rather than to combine them.

Piperine and capsaicin are both TRPV1 agonists at sensory nerve endings in the gut and mouth, which is why both taste hot and both can produce a warming sensation. Taken together the sensory and gastric effects add rather than cancel. Co-occurrence in the literature reflects that shared receptor pharmacology rather than a combination study.

Phospholipid vehicles raise the amount of a poorly water-soluble polyphenol that reaches solution in the gut, while piperine acts later by slowing conjugation and efflux. The two work at different points, so a phospholipid-formulated curcumin plus piperine is not a duplicated strategy. Note that phospholipid formulation on its own already changes exposure substantially, so the marginal piperine contribution differs from what it is in an unformulated powder.

Caffeine is cleared largely by CYP1A2, an enzyme piperine has been reported to inhibit in preclinical work, so co-administration is a plausible route to higher caffeine exposure. Both also produce a subjective warming or stimulating effect that can add. The interaction here is mechanistic and preclinical rather than measured in people at supplement doses.

Animal work at high piperine doses has reported lowered tissue glutathione, and glutathione appears in the co-occurrence index with an antagonistic flag. Those doses are far above what a standardised extract delivers in a capsule, and the finding is in animals rather than people. It is worth recording as a direction to watch rather than as an established human interaction.

A 2024 randomised, double-blind, placebo-controlled study evaluated a standardised Nigella sativa oil preparation of the type formulated with piperine for exposure reasons. Thymoquinone, the marker constituent of that oil, is cleared partly by conjugation, the step piperine slows. Because the product was tested as one preparation, the piperine share of any result is not separable.

Vitamin D3 is absorbed with dietary lipid and cleared through hydroxylation and conjugation pathways that piperine touches. That makes a rise in exposure mechanistically plausible when the two are taken together. No study cited here measured vitamin D status with and without piperine, so this stays at the level of mechanism.